« Previous
Next »
Journal of Hepatology
Volume 42, Issue 1
, Pages 61-67
, January 2005
Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors
References
- . Pattern recognition receptors: doubling up for the innate immune response. Cell. 2002;111:927–930
- Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811
- . Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002;2:151–161
- . Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science. 1998;282:480–483
- . Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109–1118
- . Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol. 2001;2:585–589
- . Hepatitis C viruses. In: Fields BN, Knipe DM, Howley PM editor. Virology. Philadelphia, PA: Lippincott; 1996;p. 1035–1058
- . Hepatitis C virus infection: when silence is deception. Trends Immunol. 2003;24:456–464
- The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 2000;288:339–344
- The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity. 2001;15:883–895
- Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med. 2002;195:35–41
- . Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med. 2002;195:43–49
- Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000;191:1499–1512
- . Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001;194:1395–1406
- Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol. 2002;169:3447–3458
- . Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood. 2004;103:1026–1029
- Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol. 2003;170:5615–5624
- . Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood. 2001;97:3171–3176
- . Impaired allostimulatory function of dendritic cells in chronic hepatitis C virus infection. Gastroenterology. 2001;120:512–524
- Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol. 1999;162:5584–5591
- Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus Core and E1 proteins. J Virol. 2002;76:5062–5070
- . HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication?. World J Gastroenterol. 2001;7:228–234
- . Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis. 2001;184:827–835
- . HCV replication in PBMC and its influence on interferon therapy. World J Gastroenterol. 2003;9:291–294
- Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol. 2000;15:431–436
- . Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Springer Semin Immunopathol. 1997;19:47–55
- Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol. 2004;172:4907–4916
- Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection. J Infect Dis. 2004;189:1646–1655
- BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001;194:1823–1834
- . Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994;45:491–503
- . Interferons alpha and beta as immune regulators—a new look. Immunity. 2001;14:661–664
PII: S0168-8278(04)00454-4
doi: 10.1016/j.jhep.2004.09.014
© 2004 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Hepatology
Volume 42, Issue 1
, Pages 61-67
, January 2005
